Nuclear Mitotic Apparatus Protein 1 (NUMA1) Peptide
NUMA1
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
-
- Target See all NUMA1 products
- NUMA1 (Nuclear Mitotic Apparatus Protein 1 (NUMA1))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- AQRLQAQLNE LQAQLSQKEQ AAEHYKLQME KAKTHYDAKK QQNQELQEQL
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of NUMA1 antibody,
Alternative Names: NUMA1 control peptide, NUMA1 antibody Blocking Peptide, Anti-NUMA1 Blocking Peptide, nuclear mitotic apparatus protein 1 Blocking Peptide, NUMA Blocking Peptide, NUMA1, NUMA-1, NUMA 1, NUMA-1 Blocking Peptide, NUMA 1 Blocking Peptide - Purification
- Immunoaffinity chromatography
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- NUMA1 (Nuclear Mitotic Apparatus Protein 1 (NUMA1))
- Background
- NuMA is a structural element in maintaining nuclear integrity. A critical spindle pole-associated mechanism, called the END (Emi1/NuMA/dynein-dynactin) network, spatially restricts APC/C activity in early mitosis. The entire coding region and exon-intron boundaries of NuMa were screened in 92 familial breast cancer patients. But the results do not support the role of NuMA variants as breast cancer susceptibility alleles.
- Molecular Weight
- 238 kDa
-
You are here:
